Objectives We have previously reported a top-ranked risk gene [i.e., serine incorporator 2 gene (SERINC2)] for alcohol dependence in individuals of European descent by analyzing the common variants in a genome-wide association study. In the present study, we comprehensively examined the rare variants [minor allele frequency (MAF) < 0.05] in the NKAIN1-SERINC2 region to confirm our previous finding.
Materials and methods A discovery sample (1409 European-American patients with alcohol dependence and 1518 European-American controls) and a replication sample (6438 European-Australian family participants with 1645 alcohol-dependent probands) were subjected to an association analysis. A total of 39 903 individuals from 19 other cohorts with 11 different neuropsychiatric and neurological disorders served as contrast groups. The entire NKAIN1-SERINC2 region was imputed in all cohorts using the same reference panels of genotypes that included rare variants from the whole-genome sequencing data. We stringently cleaned the phenotype and genotype data, and obtained a total of about 220 single-nucleotide polymorphisms in individuals of European descent and about 450 single-nucleotide polymorphisms in the individuals of African descent with 0 < MAF < 0.05 for an association analysis.
Results Using a weighted regression analysis implemented in the program SCORE-Seq, we found a rare variant constellation across the entire NKAIN1-SERINC2 region that was associated with alcohol dependence in European-Americans (Fp: overall, P = 1.8 ¾ 10 -4 ; VT: overall, P = 1.4 ¾ 10 -4 ; Collapsing, P = 6.5 ¾ 10 -5
) and EuropeanAustralians (Fp: overall, P = 0.028; Collapsing, P = 0.025), but not in African-Americans, and not associated with any other disorder examined. Association signals in this region came mainly from SERINC2, a gene that codes for an activity-regulated protein expressed in the brain that incorporates serine into lipids. In addition, 26 individual rare variants were nominally associated with alcohol dependence in European-Americans (P < 0.05). The associations of five of these rare variants that lay within SERINC2 showed region-wide significance (P < a = 0.0006) and 25 associations survived correction for a false discovery rate (q < 0.05). The associations of two rare variants at SERINC2 were replicated in EuropeanAustralians (P < 0.05). 
Conclusion

Introduction
Individuals with alcohol dependence continue to use alcohol despite adverse consequences on health, job, and family functions. Several lines of evidence have shown a major genetic component in the risk of developing alcohol dependence. Siblings of alcoholic probands had a three to eight-fold increase in the risk of developing alcohol dependence [1] . The heritability of risk for alcohol dependence was estimated to be B39% by studies of the adopted-away offspring of affected and unaffected parents [2] and as high as 60% by twin studies [3] . These studies provided evidence that genetic factors constitute a significant cause of alcohol dependence.
Recently, a gene at 6q21, that is Na + /K + transporting ATPase interacting 2 gene (NKAIN2) (alias: TCBA1), was found to have replicable associations with alcohol dependence in both the COGA family-based Caucasian (P < 10 ) [4] . This gene is highly conserved among species, transcribed in different splice variants, specific to the central nervous system [5] , and critical for neuronal functions [6] . It has also been associated with neuroticism in a genome-wide associations study (GWAS) [7] , a complex neurological phenotype [5] , and a developmental delay with recurrent infections [8] . This gene encodes a member protein, that is NKAIN2, of a mammalian protein family that includes four members, that is NKAINs 1-4, with similar conservation, distributions, and functions. All four proteins interact with the beta subunit of Na, K-ATPase (ATP1B1) that belongs to the family of Na + /K + and H + /K + ATPases b chain proteins and to the subfamily of Na + /K + -ATPases. Na + /K + -ATPase is an integral membrane protein responsible for establishing and maintaining the electrochemical gradients of Na and K ions across the plasma membrane. These electrochemical gradients are essential for osmoregulation, sodium-coupled transport of a variety of organic and inorganic molecules, and electrical excitability of nerve and muscle.
Interestingly, the NKAIN1 gene at 1p35.2, which encodes the member protein NKAIN1 from the same family as NKAIN2, is closely located to the serine incorporator 2 gene (SERINC2) that was a top-ranked risk gene (P = 2.3 Â 10 -7 ) for alcohol dependence reported by one of our recent GWASs [9] . In the present study, we comprehensively examined the rare variants [minor allele frequency (MAF) < 0.05] in the NKAIN1-SERINC2 region to confirm our previous GWAS finding that was based on common variant analysis (MAF > 0.05).
The variants with low allele frequencies are proposed to be the key for 'missing' heritability. An increasing number of human diseases have been found to be caused by a constellation of multiple rare, regionally concentrated, variants. Some association signals credited to common variants may be synthetic associations resulting from the contributions of multiple rare variants within a genomic region [10] . In these cases, the synthetic effects of region-wide rare variant constellations may be more significant than individual rare variants. In this study, on the basis of our prior work, we comprehensively examined the associations between rare NKAIN1-SERINC2 variants (MAF < 0.05) and alcohol dependence in a European-American discovery cohort and a EuropeanAustralian replication cohort.
It has been reported that alcohol dependence has a high rate of comorbidity with numerous neuropsychiatric conditions including anxiety disorders, major depression, bipolar disorders, schizophrenia, and post-traumatic stress disorder [11] [12] [13] . It has also been reported that many genes have pleiotropic effects on alcohol dependence and other neuropsychiatric conditions; for example, the autism susceptibility candidate gene 2 (AUTS2) was reported to be a risk gene for autism [14] , alcohol consumption (by a GWAS) [15] , mental retardation [16] , and heroin dependence [17] . It is known that alcohol dependence and these other neuropsychiatric conditions shared etiologies that implicate monoaminergic, cholinergic, GABAergic, and glutamatergic neurotransmission. The NKAIN1-SERINC2 region might be related to these neurotransmission systems [18] . Thus, in this study, we also examined the associations between the NKAIN1-SERINC2 variants and several other neuropsychiatric and neurological disorders available from the dbGaP database to examine whether the NKAIN1-SERINC2 variants are specific to alcohol dependence.
Materials and methods
Participants
The discovery cohort included 1409 European-American patients with alcohol dependence [Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV)] (38.3±10.2 years) and 1518 European-American controls (38.4±10.4 years). The replication cohort included 2252 EuropeanAustralian small nuclear families with 2 generations or less. These families had a total of 6438 individuals including 4342 founders and 2096 nonfounders; the latter included 1645 alcohol-dependent probands. The average family size was 2.97 individuals. These families included 3818 sibpairs, 20 half-sib-pairs, and 4192 parent-child pairs.
The discovery cohort came from the merged SAGE and COGA datasets (dbGaP access number: phs000092.v1.p1 and phs000125.v1.p1) and the replication cohort came from the OZ-ALC dataset (dbGaP access number: phs000181.v1.p1). Affected patients fulfilled the lifetime DSM-IV criteria for alcohol dependence [19] . The control participants were defined as individuals who had been exposed to alcohol (and possibly to other drugs), but never fulfilled the criteria for alcohol or substance use disorder (lifetime diagnosis). All participants were interviewed using the Semi-Structured Assessment for the Genetics of Alcoholism (SSAGA) [20] . A total of 39 903 individuals of European or African descent from 19 other dbGaP cohorts with 11 different neuropsychiatric and neurological disorders served as the contrast groups. These different neuropsychiatric and neurological disorders included alcohol dependence (in African-Americans), major depression, bipolar disorder, schizophrenia, autism, attention deficit hyperactivity disorder, Alzheimer's disease, amyotrophic lateral sclerosis, early-onset stroke, ischemic stroke, and Parkinson's disease. Diagnoses, ethnicities, study designs, and dataset names for these cohorts are shown in Table 1 . More detailed demographic information for these samples including dbGaP accession numbers, genotyping platforms, sample sizes, sex, and age structures, and mean ages has been published previously [26] [27] [28] [29] . These 21 cohorts included case-control and family-based samples, genotyped on Illumina (Illumina Inc., San Diego, California, USA), Affymetrix (Affymetrix Inc., Santa Clara, California, USA), or Perlegen microarray platforms (Perlegen Sciences Inc., Mountain View, California, USA). The discovery Table 1 Associations between the NKAIN1-SERINC2 region and different neuropsychiatric or neurological disorders Dataset names refer to dbGaP and references (GenADA: Li et al.
[21], Filippini et al. [22] ; AGP: The AGP Consortium [23] [24] [25] ). The significance level (a) is corrected for the numbers of effective genetic markers (calculated by SNPSpD). Collapsing P values for the entire NKAIN1-SERINC2 region were calculated using the program ARIEL.
AA, African-American; ADHD, attention deficit hyperactivity disorder; ALS, amyotrophic lateral sclerosis; CA, Caucasian; CC, case-control design; EA, European-American; EAu, European-Australian; Fam, family-based design; N, sample size; SNP, single nucleotide polymorphism.
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sample was genotyped on the Illumina Human 1M (Illumina Inc.) and the replication sample was genotyped on Illumina Human CNV370v1 (Illumina Inc.).
Imputation
The NKAIN1-SERINC2 region includes NKAIN1, SNRNP40, ZCCHC17, FABP3, and SERINC2. We imputed the missing single-nucleotide polymorphisms (SNPs) across the entire NKAIN1-SERINC2 region from Chr1:31,425,179 to Chr1:31,732,987 using the same reference panels to render the genetic marker sets highly consistent across different cohorts. The reference CEU panel YRI panels from two databases (i.e., 1000 genome project and HapMap 3) were adopted in the imputation for the samples of European descent and African descent, respectively. All cohorts were imputed using both programs IMPUTE2 [30] and BEAGLE [31] . We maximized the success rate and accuracy of imputation and minimized the false-positives during imputation. Only the genotypes that were imputed consistently between the two independent reference databases and consistently both by IMPUTE2 and BEAGLE were selected for analysis. The uncertainty rate of inference for missing genotypes was controlled at less than 1%. Furthermore, only the SNPs that had similar minor allele frequencies (with frequency difference <0.2%) in the healthy controls across different cohorts and HapMap database within the same ethnicity were selected for analysis. On the basis of these selection criteria, we were highly confident in the quality of these imputed genotype data. On checking the imputed genotypes in all of our four family-based cohorts, we did not find any one individual (considering all SNPs tested) or any one SNP (considering all individuals tested) with more than 0.1% Mendelian inconsistency.
Data cleaning
We stringently cleaned the phenotype and genotype data within each ethnicity before association analysis. Individuals with poor genotypic data, individuals with allele discordance, sample relatedness, individuals with a mismatch between self-identified and genetically inferred ethnicity, and individuals with a missing genotype call rate of at least 2% across all SNPs were excluded. Furthermore, we filtered out the monomorphic SNPs and the SNPs with allele discordance, Mendelian errors (in family samples), an overall missing genotype call rate of at least 2%, and MAFs greater than 0.05. We also filtered out the SNPs with missing rate differences greater than 2% between two samples that had the same phenotype and microarray platform. As a result, a total of B220 (in the individuals of European descent) and B450 (in the individuals of African descent) SNPs with 0 < MAF < 0.05 in either cases or controls were extracted for association analysis. The cleaned sample sizes and SNP numbers of all cohorts are shown in Table 1 .
Association tests for region-wide rare variant constellations
We initially tested associations between rare variant constellations and alcohol dependence using a score-type program, SCORE-Seq [32] . The mutation information was aggregated by a weighted linear combination across all rare variants of the entire NKAIN1-SERINC2 region or across each gene within the NKAIN1-SERINC2 region, and then related to alcohol dependence using regression models. Sex, age, and the first 10 principal components served as the covariates in the regression models. The principal component scores of our samples were derived from all common autosomal SNPs across the genome using principal component analysis implemented in the software package EIGENSOFT [33] . Each individual received scores on each principal component. These principal components reflected the population structure of our samples, with the first 10 principal component scores accounting for more than 95% of variance. As covariates in the regression model, these principal components controlled for population stratification and admixture effects on association analysis. The same analytic procedures were used for the other 10 neuropsychiatric and neurological disorders. For the association analyses on major depression, bipolar disorder, schizophrenia, and Alzheimer's disease, 'alcohol drinking' was also included as an additional covariate in the regression to control for the potential confounding effects of 'alcohol drinking behaviors'. This covariate was not assessed in attention deficit hyperactivity disorder, autism, amyotrophic lateral sclerosis, early-onset stroke, ischemic stroke, and Parkinson's disease.
Two tests, Fp and VT, were used to derive the overall P values. (a) In the Fp tests, the MAF upper bound threshold was fixed at 0.05, but the weight was 1/ sqrt(P(1 -P)), where P was the estimated MAF with pseudo counts in the pooled sample. (b) In the VT test, the weight was fixed at 1, whereas the threshold varied between 0 and 0.05. Statistical significance was assessed using a bootstrap procedure with one million times of resampling. Finally, these tests were confirmed using another program ARIEL [34] that used a regression-based collapsing approach.
Association tests for individual rare variants (exploratory)
For case-control samples in the discovery cohort, the allele frequencies of each SNP were compared between cases and controls using logistic regression as implemented in PLINK [35] . Diagnosis and alleles each served as the dependent and independent variables, with sex, age, and the first 10 principal components as covariates. For family samples in the replication cohort, we tested the allele-disease associations using the program FBAT [36] , assuming an additive genetic model under the null hypothesis of no linkage and association, biallelic mode, minimum number of informative families of 10 for each analysis, and offset of zero. The same analytic procedures were used for the other 10 neuropsychiatric and neurological disorders, with 'alcohol drinking', if available, as an additional covariate in the models. Different cohorts were analyzed independently. The MAFs and the minimal P values of the most significant risk SNPs and the numbers of the nominally significant risk SNPs (P < 0.05) in all cohorts are shown in Table 1 . Finally, the cumulative positive predictive values (PV + ) and the cumulative positive likelihood ratios (LR + ) of the significant (P < a) and independent (r 2 < 0.2) risk alleles across the NKAIN1-SERINC2 region were calculated using the Bayesian formula.
Correction for multiple testing in single-point association tests
The experiment-wide significance levels (a) were corrected for the numbers of effective markers that were calculated using the Bonferroni-type program SNPSpD [37] , accounting for linkage disequilibrium. Approximately 80 and 120 effective SNPs captured most of the information content of all rare variants across the entire NKAIN1-SERINC2 region in individuals of European and African descent, respectively. Thus, the corrected significance levels (a) for single-point association tests were set at 0.0006 in individuals of European descent and 0.0004 in individuals of African descent, respectively. The numbers of the statistically significant (i.e., P < a) risk SNPs in all cohorts are shown in Table 1 . The false discovery rate (q-value) for each SNP was estimated from the P values within each disease group using the R package QVALUE [38] . Finally, for those associations replicated in the European-Australian cohort, the a was set at 0.05.
Results
A rare variant constellation across the entire NKAIN1-SERINC2 region was associated with alcohol dependence in European-Americans (Fp: overall, P = 1.8 Â 10 ) and European-Australians (Fp: overall, P = 0.028; Collapsing, P = 0.025), but not in African-Americans, and not associated with any other disease examined (Collapsing, P > 0.05). When the rare variant constellation within each gene region was tested, the SERINC2 variant constellation was significantly associated with alcohol dependence in European-Americans (Fp: P = 2.7 Â 10 -4
; VT: P = 1.6 Â 10 -4 ; Collapsing, P = 8.0 Â 10 -5 ) and suggestively in EuropeanAustralians (VT: P = 0.028; Collapsing, P = 0.030) (corrected a = 0.01 for five genes within NKAIN1-SERINC2). The other four genes were suggestively (i.e., P close to 0.05) or modestly (0.01 < P < 0.05) associated with alcohol dependence in European-Americans (Tables 1  and 2 ).
Single-point association analysis showed that, among a total of 196 individual rare variants in European-Americans, 26 SNPs were nominally associated with alcohol dependence (P < 0.05). Twenty-five associations survived correction for false discovery rate (q < 0.05) and the associations of five SERINC2 variants survived Bonferroni's correction (P < a = 0.0006) ( Table 1) . If further corrected by the number of cohorts examined (i.e., n = 21), two variants (i.e., rs35961897 and rs4949405) of these five SNPs remained suggestively significant (a = 2.9 Â 10 -5
). Two independent SNPs, that is rs34278290 and rs7417775, can tag these five variants ( Table 3 ). The cumulative PV + of these two markers was 0.0791 when we used 3.81% as the 1-year prevalence rate of alcohol dependence; it was 0.2366 when we used 12.5% as the lifetime prevalence rate of alcohol dependence. Furthermore, the cumulative LR + of these Collapsing, association test using ARIEL; Fp and VT, association tests using SCORE-Seq. , located in transcription factor-binding sites; K, affecting miRNA-binding site activity; #, with significant cis-acting regulatory effects on SERINC2 mRNA expression (P = 0.024).
SERINC2 and alcohol dependence Zuo et al. 399 two markers was 2.169. Two other associations at SERINC2 were replicable (P < 0.05) between European-Americans and European-Australians (Table 4) . Among these SNPs, rs7417775 at the 3 0 -UTR of SERINC2 had significant cisacting regulatory effects on SERINC2 mRNA expression (P = 0.024; n = 45 unrelated HapMap individuals) [39] , and was predicted to affect miRNA-binding site activity; this SNP was also the most significant risk variant for Alzheimer's disease in one Caucasian sample (Tables 1  and 3 ). In addition, rs34278290 at intron 2 of SERINC2 was located in a transcript factor-binding site. Finally, no significant individual rare variant was associated with any other disease including alcohol dependence in AfricanAmericans (P > a), although this African-American cohort had a 66% power to detect the most significant risk variant, that is rs35961897.
Furthermore, we carried out transcriptome-wide mRNA expression correlation analysis in 93 European brain tissues and 80 European peripheral blood mononuclear cell samples [40] . The expression of NKAIN1-SERINC2 transcripts was correlated significantly with the expression of numerous alcoholism-related genes, mostly from the dopaminergic, serotoninergic, cholinergic, GABAergic, glutamatergic, histaminergic, endocannabinoid, metabolic, neuropeptide, and opioidergic systems [18] .
Discussion
Mainly from the association tests for the region-wide rare variant constellations, we drew the conclusion that SERINC2 was a replicable and significant risk gene specific for alcohol dependence in individuals of European descent. Results from individual variant analysis supported this conclusion. Rare SERINC2 variants may lead to a small increase in the risk for alcohol dependence on the basis of their cumulative PV + and LR + . On the basis of these results, we postulate that SERINC2 may harbor a causal variant(s) for alcohol dependence. Our study provides an additional example to support the hypothesis that region-wide rare variant constellations could have significant synthetic effects on disease phenotypes, even though the effects of individual variants might be not significant. Rare variant constellation analysis is an important tool in genetic association studies.
SERINC2 encodes serine incorporator 2 (Serinc2). Serinc2 is highly expressed in neurons of the hippocampus and cerebral cortex [41] . It is an effector in endoplasmic reticulum membranes that incorporates serine into membranes and facilitates the synthesis of phosphatidylserine and sphingolipids [42] . Phosphatidylserine is specifically distributed in the brain. Consumption of phosphatidylserine supplement has been reported to reduce the risk of dementia and cognitive dysfunction in the elderly [43, 44] , and thus has been used to treat memory deficit disorders such as Alzheimer's disease and other forms of dementia, to support cognitive functions during aging, and to remediate cognitive deficits as a result of heavy drinking and cigarette smoking. Also specifically expressed in the brain [42] , sphingolipids play a functional role in neural plasticity, signaling, and axonal guidance [45] [46] [47] . Activity of the sphingolipid metabolism enzyme, that is acid sphingomyelinase, has been reported to be increased in alcohol-dependent patients [48] . Alcohol consumption can increase sphingosine levels in the rat brains [49] . In addition, there are numerous functional variants in SERINC2 including rare variants (Table 3) , common variants, and frameshift variants such as Indels and CNVs (see NCBI dbSNPs). The function of Serinc2 altered by the alleles of these functional SERINC2 variants may be implicated in the synthesis of phosphatidylserine and sphingolipids and may thus be relevant for the development of alcohol dependence. Alternatively, correlation between the expression of NKAIN1-SERINC2 transcripts and other genes suggested that NKAIN1-SERINC2 may contribute toward alcohol dependence through other neurotransmitter or metabolic pathways [18] . For example, the glutaminergic pathway is known to play important roles in alcohol intoxication and withdrawal [50] . Within the hippocampus, Serinc2 expression is increased following seizures induced by kainite, a glutamate agonist [42] . A drug that blocks kainite glutamate receptor function appears to decrease drinking [51] . This evidence supports the glutaminergic pathway hypothesis underlying the connection between Serinc2 and alcohol dependence.
A few limitations need to be considered in the current study. The imputed genotypes were not observed directly from molecular experiments, even though their error rates and uncertainty were very low. Future work is warranted to verify these results by directly sequencing the samples. In addition, because not all neuropsychiatric and neurological disorders comorbid with alcohol dependence were exhaustively examined in the present study, we could not completely exclude the possibility that the other neuropsychiatric and neurological disorders not examined might share this SERINC2 risk gene with alcohol dependence. Furthermore, 'alcohol drinking behaviors' were not assessed in some of the neurological disorders in the present study. Their potential confounding effects on the association analysis of these disorders need to be assessed. Finally, more independent cohorts with alcohol dependence to replicate our findings in the future are also warranted.
